On January 22, 2026, insider trading disclosures revealed considerable buying and selling activity among company executives and major shareholders across multiple industries. Leading the purchasing activity was Ryan Cohen, President, CEO, and Chairman of GameStop Corp. (NYSE:GME), who acquired a substantial 1,000,000 shares over two days.
Detailed filings indicate that on January 20, Cohen purchased 500,000 GameStop shares at a weighted average price of $21.12, investing approximately $10.56 million. Subsequently, on January 21, he added another 500,000 shares at an average price of $21.60 per share, amounting to $10.80 million. These combined investments equate to a total of about $21.36 million. Current market data shows GameStop shares trading at $23.15, reflecting a positive year-to-date return of 8.02%, with a beta value of -1.21, signalling relative stability or inverse movement compared to the market.
In another notable case, Mawson Infrastructure Group Inc. (NASDAQ:MIGI) experienced considerable acquisition activity by the Endeavor Investor Group. This consortium, comprised of Endeavor Blockchain, LLC, PM Squared LLC, Cody Smith, and Joshua Allen Kilgore, executed share purchases totaling $4.38 million from November 26 to December 16, 2025. The purchase prices ranged broadly from $4.03 to $12.00 per share. Mawson Infrastructure is currently priced at $4.46 per share, significantly beneath its 52-week high of $40.00. Despite an enterprise burdened by high leverage and fragile financial health, industry analysis suggests the prospect of profitability during the current fiscal year.
Investment activity was also seen in ASA Gold & Precious Metals Ltd (NYSE:ASA), where sizable shareholder Saba Capital Management, L.P., which holds a ten-percent stake, increased its ownership. The firm acquired 3,723 shares at $66.08 each, for a total investment exceeding $246,000. This increment raises Saba Capital’s holding in ASA Gold & Precious Metals Ltd to 5,465,362 shares.
RENN Fund, Inc. (EXCHANGE:RCG) likewise saw insider buying when its President and Co-Portfolio Manager, Murray Stahl, purchased 1,134 shares priced at $2.70 on January 21, 2026. This transaction valued at roughly $3,061, complements the fund’s profile trading near $2.69 with a market capitalization of $18.84 million. The fund demonstrates strong financial characteristics including a price-to-earnings ratio of 5.1, a remarkable 36.96% revenue growth over the past year, and a gross profit margin of 100%.
Commercial Metals Co (NYSE:CMC) Director Dennis V. Arriola completed a transaction on January 20, acquiring 2,000 shares at $74.69 each. This purchase totaled $149,380 and increased Arriola’s direct shareholding to 9,238 shares.
On the selling side, Apogee Therapeutics, Inc. (NASDAQ:APGE) experienced a notable divestment when Fairmount Healthcare Fund II L.P. sold 1,750,000 shares at $76.30 per share on January 22, amounting to $133.5 million. These sales transpired as APGE’s stock traded near its 52-week high of $84.56 and followed an almost 99% increase over the last year. Post-sale, the fund retains 298,647 common shares and 6,743,321 non-voting common shares convertible into voting stock.
Similarly, Cogent Biosciences (NASDAQ:COGT) director Fairmount Funds Management LLC executed a share sale of 3,500,000 common shares at $36.40 each for total proceeds of $127.4 million on the same date. The shares exchanged hands near COGT’s 52-week peak of $43.73, following extraordinary gains of 344% over the last 12 months and 219% in the preceding six months. The fund’s remaining direct ownership stands at 5,503,418 shares, corresponding to a valuation near $6.1 billion.
Snowflake Inc. (NASDAQ:SNOW) also witnessed insider selling, with Director Frank Slootman divesting 180,070 shares from January 20, for approximately $41.35 million across price points between $205.46 and $209.20 per share. Concurrently, Slootman acquired 200,000 shares through stock option exercises at a strike price of $8.88, investing $1.78 million. Snowflake’s current share price rests at $211.13, with an expansive market capitalization of $72.24 billion.
At Natera Inc. (NASDAQ:NTRA), Chief Financial Officer Michael Burkes Brophy sold 60,723 shares over January 20 and 21, generating proceeds around $14.6 million with prices ranging from $234.74 to $242.67 per share. On January 20, Brophy sold 23,948 shares at $234.74; on the following day, he sold 602 shares at $235 and 36,573 shares at $242.67. CEO Steven Leonard Chapman simultaneously liquidated 73,522 shares over the same two-day span for approximately $17.2 million. These sales, executed between $234.74 and $235, aimed to fulfill tax obligations associated with the vesting of restricted stock units.
Rationale for Tracking Insider Transactions
Insider activity offers significant insights into corporate leadership's perspectives on their companies' outlooks. Insider purchases frequently signal optimism and confidence in future performance, while sales can indicate valuation concerns or personal financial strategies. However, insider trades must be interpreted within context and alongside broader financial analysis when considering investment decisions.